Relationship between genetic polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase as risk factors for type 2 diabetes in Tunisian patients

Clinical Biochemistry

Volumn 43, Issue 3, 2010, Pages 259-266

  Mehri, Sounira ^a,b   Koubaa, Nadia ^a   Nakbi, Amel ^a   Hammami, Sonia ^a,c   Chaaba, Raja ^a   Mahjoub, Sinda ^b   Zouari, Bechir ^d   Abid, Mohamed ^e   Arab, Saida Ben ^b   Baudin, Bruno ^f   Hammami, Mohamed ^a  

^a UR03 ES 08 Human Nutrition and Metabolic Disorders Faculty of Medicine   (Tunisia)

^b Unity of Genetic   (Tunisia)

^c FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^d UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^e HEDI CHAKER HOSPITAL   (Tunisia)

^f HÔPITAL SAINT ANTOINE   (France)

Author keywords

ACE; ACE activity; Homocysteine levels; MTHFR; Polymorphism; Type 2 diabetes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; HOMOCYSTEINE; METFORMIN; SULFAMIDE DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIET THERAPY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; SEX DIFFERENCE; TUNISIA; VOLUNTEER;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; TUNISIA;

EID: 74249118820     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.008     Document Type: Article

References (44)

1. Ruiz J. Diabetes mellitus and the late complications: influence of the genetic factors. Diab. Metab. 2 (1997) 57-63
2. Lander E.S. The new genomics: global views of biology. Science 274 (1996) 536-539
3. Trégouet D.A., Aubert H., Henry M., Morange P., Visvikis S., Juhan-Vague I., et al. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms. Hum. Genet. 109 (2001) 191-197
4. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
5. Winkelmayer W.C., Huber A., Wagner O.F., Hörl W.H., Sunder-Plassmann G., and Födinger M. Associations between MTHFR 1793G-A and plasma total homocysteine, folate, and vitamin B12 in kidney transplant recipients. Kidney Int. 67 (2005) 1980-1985
6. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
7. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., and Rosenberg I.H. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
8. Smaoui M., Hammami S., Chaaba R., Attia N., Hamda K.B., and Masmoudi A.S. Lipids and lipoprotein (a) concentration in Tunisian type 2 diabetic patients relationship to glycaemic control and coronary heart disease. J. Diabetes Its Complicat. 18 (2004) 258-263
9. Baudin B., Bénéteau-Burnat B., Crayon B., and Giboudeau J. Automated kinetic assay of angiotensin-converting enzyme on synchrone CX-4. Clin. Chem. Enzym. Comms. 7 (1995) 41-48
10. Ducros V., Schimitt D., Pernod G., Faure H., Polack B., and Favier A. Gas chromatographic mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution: method and clinical application. J. B. Chromatogr. 729 (1999) 333-339
11. Miller S., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
12. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidas 1). Nucl. Acids Res. 20 (1992) 1433
13. Shanmugan V., Sell K.W., and Saha B.K. Mistyping ACE heterozygotes. PCR Methods Applications 3 (1993) 120-121
14. Movva S., Alluri R.V., Komandur S., Vattam K., Eppa K., Mukkavali K.K., et al. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J. Diabetes Complications 21 (2007) 237-241
15. Czupryniak L., Młynarski W., Pawłowski M., Saryusz-Wolska M., Borkowska A., Klich I., et al. Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism. Diabetes. Res. Clin. Pract. 80 (2008) 386-391
16. Feng Y., Niu T., Xu X., Chen C., Li Q., Qian R., et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 51 (2002) 1986-1988
17. Stephens J.W., Dhamrait S.S., Acharya J., Humphries S.E., and Hurel S.J. A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus. J. Diabetes Its Complicat. 20 (2006) 317-321
18. Arzu Ergen H., Hatemi H., Agachan B., Camlica H., and Isbir T. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp. Mol. Med. 36 (2004) 345-350
19. Grammer T.B., Renner W., von Karger S., Boehm B.O., Winkelmann B.R., and Maerz W. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography (The Ludwigshafen Risk and Cardiovascular Health Study). Mol. Genet. Metab. 88 (2006) 378-383
20. Koubaa N., Nakbi A., Smaoui M., Abid N., Chaaba R., and Abid M. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors. Clin. Biochem. 40 (2007) 1007-1014
21. Nikzamir A., Nakhjavani M., Golmohamadi T., and Dibai L. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch. Iran. Med. 11 (2008) 3-9
22. Han T.Y., Li Z.L., and Ye H.M. Relationship of the disease severity with ACE gene polymorphism and serum ACE activity in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 10 (2008) 693-696
23. Schieffer B., and Drexler H. ACE gene polymorphism and coronary artery disease. A question of persuasion or statistical confusion?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 281-282
24. Van Dijk M.A., Kroon I., Kamper A.M., Boomsma F., Danser A.H., and Chang P.C. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. J. Cardiovasc. Pharmacol. 35 (2000) 484-490
25. Sanada M., Higashi Y., Nakagawa K., Sasaki S., Kodama I., and Tsuda M. Relationship between the angiotensin converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women. J. Am. Coll. Cardiol. 37 (2001) 1529-1535
26. Shimizu E., Hashimoto K., Ohgake S., Koizumi H., Okamura N., and Koike K. Association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and novelty seeking personality in healthy females. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 99-103
27. Keavney B., McKenzie C.A., Connell J.M., Julier C., Ratcliffe P.J., Sobel E., et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum. Mol. Genet. 7 (1998) 1745-1751
28. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin. Chem. Lab. Med. 40 (2002) 255-265
29. Helfenstein T., Fonseca F.A., Relvas W.G., Santos A.O., Dabela M.L., Matheus S.C., et al. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin. Chim. Acta 355 (2005) 165-172
30. Sun J., Xu Y., Zhu Y., and Lu H. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res. Clin. Pract. 64 (2004) 185-190
31. Ndrepepa G., Kastrati A., Braun S., Koch W., Kolling K., and Mehilli J. Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr. Metab. Cardiovascular. Diseases 18 (2008) 66-73
32. Benes P., Kanková K., Muzík J., Groch L., Benedík J., and Elbl L. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol. Genet. Metab. 73 (2001) 188-195
33. Moczulski D., Fojcik H., Zukowska-Szczechowska E., Szydlowska I., and Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol. Dial. Transplant. 18 (2003) 1535-1540
34. Chango A., Potier De Courcy G., Boisson F., Guilland J.C., Barbé F., Perrin M.O., et al. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br. J. Nutr. 84 (2000) 891-986
35. Kluijtmans L.A., Young I.S., Boreham C.A., Murray L., McMaster D., McNulty H., et al. Whitehead, Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101 (2003) 2483-2488
36. Brown K.S., Kluijtmans L.A., Young I.S., Murray L., McMaster D., Woodside J.V., et al. The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 174 (2004) 315-322
37. Cugini P., Baldoni F., De Rosa R., Pandolfi C., Colotto M., Buccarella P.A., et al. Higher blood pressure load (baric impact) in normotensives with endothelial dysfunction: a paraphysiological status of "pre-hypertension". Clin. Ter. 153 (2002) 309-315
38. Biselli P.M., Abbud-Filho M., Ferreira-Baptista M.A., de Alvarenga M.P., Goloni-Bertollo E.M., and Pavarino-Bertelli E.C. Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy. Transplant. Proc. 38 (2006) 1327-1328
39. Li C., Zhang C., Qiu S., Lu X., Zeng Y., Wu H., et al. Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic stroke. Zhonghua Yixue Zazhi 82 (2002) 1046-1049
40. Wang H.Y., Li C.M., Wang Z., and Yang F. Relationships between polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase genes and genetic susceptibility to pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 39 (2004) 369-372
41. Joshi G., Pradhan S., and Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J. Neurol. Sci. 277 (2009) 133-137
42. Goracy I. Polymorphism of genes coding for angiotensin I converting enzyme and methylenetetrahydrofolate reductase in patients with ischemic heart disease. Ann. Acad. Med. Stetin. 46 (2000) 97-108
43. Vettriselvi V., Vijayalakshmi K., Paul S.F., and Venkatachalam P. ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. J. Obstet. Gynaecol. Res. 34 (2008) 301-306
44. Zak I., Niemiec P., Sarecka B., Balcerzyk A., Ciemniewski Z., and Rudowska E. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677->T transition in the MTHFR gene. Acta Biochim. Pol. 50 (2003) 527-534